S. Schuster

Radiation in Combination with Bispecific Therapy Does Not Suggest Excess Toxicity in B-Cell Lymphomas

Monica Chelius, Jonathan Baron, Nikhil Yegya‐Raman, Elise A. Chong et autres

us (code pays fourni par la source)

60P Adaptive NK cells as a therapeutic option for childhood leukaemia

Zohreh Eskandarian, Richard Hauch, Michael Spohn, A-L. Heitmann et autres

Background: Cell therapy has emerged as a promising approach in cancer treatment, leveraging the potential of the patient's immune system to fight tumors.However, the assessment of the efficacy and safety of these therapies remains a significant challenge, since the current available approaches …

de (code pays fourni par la source)

1229P Selective phenotypic and genotypic evaluation of circulating glial cells for improved diagnosis of glial malignancies

Sewanti Limaye, Farzad Massoudi, N. Rohatgi, Dadasaheb Akolkar et autres

in, us, gb (code pays fourni par la source)

Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for early‐stage classical Hodgkin Lymphoma: Updated results from an ongoing phase 2 study (SGN35‐027 Part C)

Jeremy S. Abramson, David J. Straus, Nancy L. Bartlett, J. M. Burke et autres

Introduction: Brentuximab vedotin (BV) and nivolumab are well tolerated, active treatments for patients (pts) with classical Hodgkin lymphoma (cHL) (Advani 2021; Yasenchak 2020). Herein, we present updated efficacy and safety results from an ongoing phase 2 study of a novel combination of …

us, es, pl, it, au (code pays fourni par la source)

Radiation Therapy (RT)-Based Salvage Therapy for Classical Hodgkin Lymphoma (cHL)

Shwetha Manjunath, Meredith I LaRose, Marco D. Carpenter, Jakub Svoboda et autres

us (code pays fourni par la source)

PR01.01 Evaluation of Circulating Tumor Cells for Non-Invasively Discerning Lung Primary from Metastasis

D. A. Patil, Sewanti Limaye, Dadasaheb Akolkar, Pooja Fulmali et autres

in (code pays fourni par la source)

OFP01.05 Circulating Ensembles of Tumor Associated Cells Facilitate Efficient Triaging of Asymptomatic Individuals for Low Dose Computed Tomography

Dadasaheb Akolkar, D. A. Patil, Sewanti Limaye, Pooja Fulmali et autres

in (code pays fourni par la source)

SP-0129: Translating research into optimal health: State of the art of CAR-T cell therapy in hematological malignancies

S. Schuster

AGE, PERFORMANCE STATUS AND LENALIDOMIDE THERAPY INDEPENDENTLY INFLUENCE THE OUTCOME OF PATIENTS WITH MYELODYSPLASTIC SYNDROME WITH ISOLATED DEL(5Q) FROM SOUTH AMERICA

Raymundo Soares Azevedo, Carolina Belli, M.A. Perussini, L Ferri et autres

br, ar (code pays fourni par la source)

73P Anti-angiokinases in patient-specific combination regimens can improve outcomes in advanced metastatic cancers

D. A. Patil, Dadasaheb Akolkar, Navin Srivastava, V. Datta et autres

in (code pays fourni par la source)

47P Improved treatment outcomes by using patient-specific drug combinations in mTOR activated advanced metastatic cancers

Dadasaheb Akolkar, D. A. Patil, Navin Srivastava, V. Datta et autres

in (code pays fourni par la source)

Encyclopedic tumor analysis guided personalized treatments for advanced refractory breast cancer

S. Schuster, V. Datta, Dadasaheb Akolkar, Ajay Srinivasan et autres

Background Standard of Care systemic regimens have limited efficacy in advanced refractory breast cancers and offer diminishing benefits with each subsequent line. We hypothesized that integrative molecular and cellular investigations (‘Encyclopedic Tumor Analysis’, ETA) can reveal unexplored vulnerabilities in refractory breast cancer …

in (code pays fourni par la source)